Clinical Trial Update: Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing continuing lamivudine plus adefovir versus switching to entecavir plus adefovir in lamivudine-resistant chronic hepatiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)
• Hepsera (adefovir dipivoxil)
• Lamivudine (lamivudine)

Snippet

Sponsor: Asan Medical Center | Conditions: Hepatitis B, Chronic | Phase 4 | Status: UNKNOWN